Beta-lactam antibiotics use in intensive care units--the pathophysiological, pharmacokinetic, pharmacodynamic and pharmacoeconomic approach

Vojnosanit Pregl. 2015 Feb;72(2):175-80. doi: 10.2298/vsp1502175p.
No abstract available

MeSH terms

  • Anti-Bacterial Agents / economics
  • Anti-Bacterial Agents / pharmacology*
  • Critical Illness
  • Drug Monitoring
  • Humans
  • Intensive Care Units*
  • Sepsis / drug therapy
  • beta-Lactamases / pharmacology*

Substances

  • Anti-Bacterial Agents
  • beta-Lactamases